(3R,4S,5R,6R)-6-(Hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Term ID

CHEBI:151970

Synonyms

alpha-D-gluco-hexopyranosyl-(1->6)-alpha-D-galacto-hexopyranosyl-(1->2)-D-galacto-hexopyranose
Glc(a1-6)Gal(a1-2)Gal
WURCS=2.0/3,3,2/[a2112h-1x_1-5][a2112h-1a_1-5][a2122h-1a_1-5]/1-2-3/a2-b1_b6-c1

Definition

References

GlyGen:G50695RX
GlyTouCan:G50695RX

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3R,4S,5R,6R)-6-(Hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype where environments contain (3R,4S,5R,6R)-6-(Hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype modified by environments containing (3R,4S,5R,6R)-6-(Hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype affecting (3R,4S,5R,6R)-6-(Hydroxymethyl)-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Human Disease Model